Two major biotech companies in the stem cell industry sign yet another licensing agreement.
The biotech company Medistem demonstrates the therapeutic value of allogeneic endometrial regenerative cells in the treatment of critical limb ischemia.
The Harvard Stem Cell Institute announces the creation of 20 new, non-stem cell, cell lines which target specific diseases.
The biotech company Pluristem Therapeutics has developed an adult stem cell product for the prevention of clinical symptoms of multiple sclerosis.
Adult stem cells derived from bone marrow are used to treat restenosis in an animal model.
Adult stem cells taken from the dental pulp of teeth have been shown to promote the proliferation and differentiation of endogenous neural cells in an animal model.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.